Page last updated: 2024-11-04

sevoflurane and Demyelinating Diseases

sevoflurane has been researched along with Demyelinating Diseases in 1 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Xue, H1
Zhang, YH1
Gao, QS1
Wu, ZY1
Niu, JY1
Li, C1
Zhao, P1

Other Studies

1 other study available for sevoflurane and Demyelinating Diseases

ArticleYear
Sevoflurane Post-Conditioning Ameliorates Neuronal Deficits and Axon Demyelination After Neonatal Hypoxic Ischemic Brain Injury: Role of Microglia/Macrophage.
    Cellular and molecular neurobiology, 2021, Volume: 41, Issue:8

    Topics: Animals; Animals, Newborn; Axons; Brain; Demyelinating Diseases; Female; Hypoxia-Ischemia, Brain; Is

2021